Results 131 to 140 of about 2,349 (173)
Some of the next articles are maybe not open access.

Pharmaceutical cocrystals: An overview

International Journal of Pharmaceutics, 2011
Pharmaceutical cocrystals are emerging as a new class of solid drugs with improved physicochemical properties, which has attracted increased interests from both industrial and academic researchers. In this paper a brief and systematic overview of pharmaceutical cocrystals is provided, with particular focus on cocrystal design strategies, formation ...
Ning Qiao   +2 more
exaly   +4 more sources

Recent Advances on the Biological Study of Pharmaceutical Cocrystals

AAPS PharmSciTech, 2022
As a low-risk, low-cost, but high-reward route, cocrystallization of drugs with appropriate coformers is applied to improve the physiochemical and biopharmaceutical properties of drugs. Currently, most researchers concentrate their efforts on the preparation, characterization, and improvement of physicochemical properties of pharmaceutical cocrystals ...
Zhipeng Wang   +2 more
exaly   +3 more sources

Pharmaceutical cocrystals and poorly soluble drugs

International Journal of Pharmaceutics, 2013
In recent years cocrystal formation has emerged as a viable strategy towards improving the solubility and bioavailability of poorly soluble drugs. In this review the success of numerous pharmaceutical cocrystals for the improvement of the solubility and dissolution rates of poorly soluble drugs is demonstrated using various examples taken from the ...
Ranjit Thakuria   +2 more
exaly   +3 more sources

Pharmaceutical Cocrystals of Diflunisal and Diclofenac with Theophylline

Molecular Pharmaceutics, 2014
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (DIC) with theophylline (THP) were obtained, and their crystal structures were determined. In both of the crystal structures, molecules form a hydrogen bonded supramolecular unit consisting of a centrosymmetric dimer of THP and two molecules of active ...
Artem O Surov   +2 more
exaly   +3 more sources

Challenges in Translational Development of Pharmaceutical Cocrystals

Journal of Pharmaceutical Sciences, 2017
The last 2 decades have witnessed increased research in the area of cocrystals resulting in deeper scientific understanding, increase in intellectual property landscape, and evolution in the regulatory environment. Pharmaceutical cocrystals have received significant attention as a new solid form on account of their ability to modulate poor ...
Dnyaneshwar P Kale, Arvind K Bansal
exaly   +3 more sources

Crystal Engineering of Pharmaceutical Cocrystals [PDF]

open access: yes, 2011
Cocrystals have recently gained attention as attractive alternate solid forms for drug development. A pharmaceutical cocrystal is a single crystalline homogenous phase consisting of a drug molecule and ligand i.e. cocrystal former that is excipient or another drug molecule [1,2].
Cvetkovski, Aleksandar, Gulaboski, Rubin
core   +3 more sources

Stability screening of pharmaceutical cocrystals

Pharmaceutical Development and Technology, 2021
An efficient protocol for assessing both the chemical and physical stability of cocrystalline forms of active pharmaceutical ingredients (APIs) is proposed. In this protocol, the cocrystalline material is used to prepare two standard formulations, mimicking wet granulations, to make low-dose tablets.
Kenneth C, Waterman   +5 more
openaire   +2 more sources

Cocrystal: A Review on the Design and Preparation of Pharmaceutical Cocrystals

Asian Journal of Research in Pharmaceutical Sciences, 2023
The majority of the active pharmaceutical components have issues with poor solubility, bioavailability, chemical stability, and moisture absorption. Pharmaceutical crystals are a reliable way to change the aforementioned physicochemical properties of drugs without changing their pharmacological behaviour.
Tanmay Jit   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy